We are live on ! Find out more
DLA

Douglas Lane & Associates Portfolio holdings

AUM $7.37B
1-Year Est. Return 21.9%
This Fund
S&P 500
This Quarter Est. Return
+6.77%
1 Year Est. Return
+21.9%
3 Year Est. Return
+71.89%
5 Year Est. Return
+87.03%
10 Year Est. Return
+444.88%
AUM
$7.18B
AUM Growth
+$277M
Cap. Flow
-$59.6M
Cap. Flow %
-0.83%
Top 10 Hldgs %
23.97%
Holding
248
New
10
Increased
74
Reduced
146
Closed
8

Top Buys

Rank Stock Value
1
IT icon
Gartner
IT
+$33M
2
AMZN icon
Amazon
AMZN
+$21.6M
3
DHR icon
Danaher
DHR
+$14.6M
4
APD icon
Air Products & Chemicals
APD
+$13.2M
5
CRM icon
Salesforce
CRM
+$12.9M

Top Sells

Rank Stock Value
1
SLB icon
SLB Ltd
SLB
+$49.7M
2
ORCL icon
Oracle
ORCL
+$31.4M
3
NVDA icon
NVIDIA
NVDA
+$20.3M
4
AXP icon
American Express
AXP
+$18.6M
5
JPM icon
JPMorgan Chase
JPM
+$16.6M

Sector Composition

Rank Sector Weight
1 Technology 18.81%
2 Financials 17.13%
3 Healthcare 13.1%
4 Industrials 12.77%
5 Communication Services 7.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
C icon
51
Citigroup
C
$226B
$52.8M 0.74%
519,830
-44,940
-8% -$4.26M
TFC icon
52
Truist Financial
TFC
$64B
$52.3M 0.73%
1,143,828
-11,336
-1% -$511K
WPM icon
53
Wheaton Precious Metals
WPM
$60.9B
$51.2M 0.71%
457,435
-33,665
-7% -$3.29M
VMC icon
54
Vulcan Materials
VMC
$36.9B
$50.6M 0.7%
164,392
+9,029
+6% +$2.56M
TECK icon
55
Teck Resources
TECK
$32.6B
$50.5M 0.7%
1,150,076
+112,100
+11% +$4.07M
AES icon
56
AES
AES
$10.5B
$49.9M 0.69%
3,788,631
+144
+0% +$1.87K
RACE icon
57
Ferrari
RACE
$72.5B
$49.7M 0.69%
102,349
-5,277
-5% -$2.53M
BUD icon
58
AB InBev
BUD
$165B
$49.6M 0.69%
831,372
-138,801
-14% -$8.73M
GSK icon
59
GSK
GSK
$106B
$48.4M 0.67%
1,120,899
-196,210
-15% -$7.66M
PYPL icon
60
PayPal
PYPL
$50.5B
$48M 0.67%
715,404
-9,264
-1% -$653K
IBM icon
61
IBM
IBM
$224B
$47.4M 0.66%
168,038
-14,854
-8% -$3.89M
GOOGL icon
62
Alphabet (Google) Class A
GOOGL
$4.33T
$47M 0.65%
193,168
-7,036
-4% -$1.47M
DEO icon
63
Diageo
DEO
$53.6B
$46.2M 0.64%
483,949
+64,659
+15% +$6.79M
MRK icon
64
Merck
MRK
$318B
$45.3M 0.63%
539,350
+19,449
+4% +$1.6M
ZTS icon
65
Zoetis
ZTS
$30B
$44.9M 0.63%
306,753
+79,906
+35% +$12.1M
AAPL icon
66
Apple
AAPL
$4.57T
$44.4M 0.62%
174,473
+727
+0.4% +$164K
EL icon
67
Estee Lauder
EL
$32B
$44.4M 0.62%
503,330
-954
-0.2% -$85K
AA icon
68
Alcoa
AA
$13.2B
$42.5M 0.59%
1,293,538
-16,027
-1% -$498K
ZBH icon
69
Zimmer Biomet
ZBH
$18.4B
$42.5M 0.59%
431,360
+29,011
+7% +$2.87M
CVS icon
70
CVS Health
CVS
$122B
$42.5M 0.59%
563,420
-28,965
-5% -$1.99M
UAL icon
71
United Airlines
UAL
$42.1B
$39.1M 0.54%
404,986
-28,654
-7% -$2.76M
INTU icon
72
Intuit
INTU
$89B
$38.7M 0.54%
56,669
+11,789
+26% +$8.5M
SPG icon
73
Simon Property Group
SPG
$72.3B
$38.7M 0.54%
206,034
-5,162
-2% -$891K
WCN
74
Waste Connections
WCN
$42B
$37.7M 0.52%
214,289
+59,457
+38% +$10.8M
GM icon
75
General Motors
GM
$76.8B
$37.5M 0.52%
615,177
-27,774
-4% -$1.55M

Similar funds

Douglas Lane & Associates's Q3 2025 Portfolio in Review

As of Q3 2025, Douglas Lane & Associates held 248 positions worth $7.18B, up 4% from $6.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Douglas Lane & Associates's Q3 2025 filing shows 10 new, 74 increased, 146 reduced and 8 closed positions. Its largest new stake was Synopsys: 840 shares worth $414K. The largest sale was SLB Ltd, an estimated $49.7M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

  • Douglas Lane & Associates's largest Q3 2025 buy was Synopsys: 840 shares worth $414K.
  • Douglas Lane & Associates added most to Gartner in Q3 2025, an estimated $33M increase.
  • Douglas Lane & Associates's biggest Q3 2025 reduction was Oracle, cutting an estimated $31.4M.
  • Douglas Lane & Associates fully exited SLB Ltd in Q3 2025, selling an estimated $49.7M.
  • Douglas Lane & Associates's ten largest holdings make up 24% of its $7.18B portfolio in Q3 2025.
  • Douglas Lane & Associates opened 10 new positions and closed 8 in Q3 2025.
  • Douglas Lane & Associates's portfolio value rose 4% quarter-over-quarter to $7.18B.

Based on Douglas Lane & Associates's 13F filing for Q3 2025, filed 10 Oct 2025.